ShiA abrogates the innate T-cell response to Shigella flexneri infection

Molly A Ingersoll1, Arturo Zychlinsky

  • 1Max Planck Institute for Infection Biology, 21/22 Schumannstrasse, 10117 Berlin, Germany.

Infection and Immunity
|March 23, 2006
PubMed

Insights

Shigella flexneri uses the virulence factor ShiA to suppress the host's innate T-cell response, reducing inflammation and improving survival during infection. This finding highlights ShiA's role in modulating host immunity.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Shigella spp. cause bacillary dysentery, leading to acute colonic injury driven by host inflammatory responses.
  • The virulence factor ShiA, encoded by the SHI-2 pathogenicity island, is known to down-regulate inflammation during Shigella infections.
  • Previous studies in rabbit models indicated that ShiA modulates inflammation, with null strains causing more severe inflammation and overexpressing strains being less inflammatory.

Purpose of the Study:

  • To investigate the host responses modulated by the Shigella virulence factor ShiA.
  • To determine the role of ShiA in modulating innate T-cell responses during Shigella infection.
  • To evaluate the impact of ShiA expression on host survival and bacterial clearance in a mouse model.

Main Methods:

  • Infection studies were conducted using a mouse lung model, recapitulating phenotypes observed in rabbit ileal loop models.
  • Microarray analysis was employed to identify host gene expression changes in infected lungs.
  • Immunohistochemistry was used to quantify polymorphonuclear leukocytes (PMN) and T cells in lung tissues.

Main Results:

  • Mice infected with a ShiA-overexpressing (ShiA+) strain cleared bacteria and survived, unlike those infected with wild-type or shiA null (DeltashiA) strains, which succumbed to infection.
  • Microarray analysis revealed significant regulation of genes associated with innate T-cell responses in infected lungs.
  • Immunohistochemistry showed reduced numbers of PMN and T cells in the lungs of ShiA+-infected mice compared to wild-type and DeltashiA-infected mice.

Conclusions:

  • The virulence factor ShiA suppresses the innate T-cell response during Shigella infections.
  • ShiA plays a critical role in modulating host immunity, leading to improved bacterial clearance and survival.
  • Targeting ShiA-mediated immune suppression could offer novel therapeutic strategies for Shigella infections.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...